Paolo Pucci
CIK: 0001436861
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- May 4, 2026WST
WEST PHARMACEUTICAL SERVICES INC
Award(A)Direct791 shares- - Apr 1, 2026REPL
Replimune Group, Inc.
Award(A)DirectStock Option (right to buy)
44.5K shares- - Dec 12, 2025MRUS
Merus N.V.
Disposition(D)DirectShare Option (right to buy)
8.8K shares- - Dec 12, 2025MRUS
Merus N.V.
Disposition(D)DirectShare Option (right to buy)
14.4K shares- - Dec 12, 2025MRUS
Merus N.V.
Disposition(D)DirectShare Option (right to buy)
13.2K shares- - Dec 12, 2025MRUS
Merus N.V.
Disposition(D)DirectShare Option (right to buy)
16.6K shares- - Dec 12, 2025MRUS
Merus N.V.
Disposition(D)DirectShare Option (right to buy)
6.1K shares- - Dec 12, 2025MRUS
Merus N.V.
Disposition(D)DirectShare Option (right to buy)
17.3K shares- - May 22, 2025MRUS
Merus N.V.
Award(A)DirectShare Option (right to buy)
13.2K shares- - May 6, 2025WST
WEST PHARMACEUTICAL SERVICES INC
Award(A)Direct1.1K shares- - Apr 1, 2025REPL
Replimune Group, Inc.
Award(A)DirectStock Option (right to buy)
32K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 4, 2026 |  WST WEST PHARMACEUTICAL SERVICES INC | Award(A) | 791 | - | $0 | Direct |
| Apr 1, 2026 |  REPL Replimune Group, Inc. | Award(A) Stock Option (right to buy) | 44,500 | - | - | Direct |
| Dec 12, 2025 |  MRUS Merus N.V. | Disposition(D) Share Option (right to buy) | 8,844 | - | - | Direct |
| Dec 12, 2025 | MRUS Merus N.V. | Disposition(D) Share Option (right to buy) | 14,414 | - | - | Direct |
| Dec 12, 2025 | MRUS Merus N.V. | Disposition(D) Share Option (right to buy) | 13,193 | - | - | Direct |
| Dec 12, 2025 | MRUS Merus N.V. | Disposition(D) Share Option (right to buy) | 16,604 | - | - | Direct |
| Dec 12, 2025 | MRUS Merus N.V. | Disposition(D) Share Option (right to buy) | 6,120 | - | - | Direct |
| Dec 12, 2025 | MRUS Merus N.V. | Disposition(D) Share Option (right to buy) | 17,262 | - | - | Direct |
| May 22, 2025 | MRUS Merus N.V. | Award(A) Share Option (right to buy) | 13,193 | - | - | Direct |
| May 6, 2025 | WST WEST PHARMACEUTICAL SERVICES INC | Award(A) | 1,071 | - | - | Direct |
| Apr 1, 2025 | REPL Replimune Group, Inc. | Award(A) Stock Option (right to buy) | 32,000 | - | - | Direct |
1-11 of 11 transactions
About Pucci Paolo
Pucci Paolo (SEC CIK 0001436861) files insider reports with the SEC as Director of WEST PHARMACEUTICAL SERVICES INC (WST), Director of Replimune Group, Inc. (REPL) and Director of Merus N.V. (MRUS).
Signal8 holds 6 ownership filings by Pucci Paolo, all Form 4s, filed between Apr 3, 2025 and May 6, 2026. Those filings report 11 transactions, from Apr 1, 2025 to May 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Pucci Paolo's filings is in WOBURN, MA.
Recent filings by Pucci Paolo
- May 4, 2026: Grant or award of WST shares (Form 4, code A).
- Apr 1, 2026: Grant or award of REPL derivative securities (Form 4, code A).
- Dec 12, 2025: Disposition to issuer transactions of MRUS derivative securities (6 lines, Form 4, code D).
- May 22, 2025: Grant or award of MRUS derivative securities (Form 4, code A).
- May 6, 2025: Grant or award of WST shares (Form 4, code A).
Other insiders filing for WEST PHARMACEUTICAL SERVICES INC (WST)
- HAUGEN JANET BRUTSCHEA, Director
- Favorite Annette F, Sr. VP & Chief HR Officer
- Lagarde Michel, President and CEO
- McMahon Robert W., SVP & Chief Financial Officer
- Campbell Shane Alden, SVP, Proprietary Segment
- Michels Douglas A, Director